CaRAVAN's overarching mission is to support the advancement of research in vascular anomalies.
Progress towards understanding and developing better treatments for vascular anomalies can be slow, especially when there are only a few scientists doing research in this unique area.
There is a great need in the study of vascular anomalies and especially of the lymphatic system for highly skilled PhDs and physician-scientists, who have gone to medical school and completed successful PhD training (MD-PhD) and plan to dedicate their work to this area of study.
CaRAVAN's strategy to fill this gap: ENGAGE early researchers and clinician-scientists by providing them the opportunities and exposure to this fascinating and incredibly important field of medicine.
Working with our patient advocacy organizations, researchers and clinicians, CaRAVAN has initiated THE POWER-OF-ONE FELLOWSHIPS.
The goal of these fellowships is to support a PhD or MD-PhD student interested in focusing on the study of vascular anomalies.
With the help of our patient community, CaRAVAN will organize and raise the funds needed to support an undergraduate MD, MD-PhD or PhD student who is interested to work in a vascular anomaly related lab and completing their thesis work in this field.
Our first fellowship campaign in 2022 was a resounding success!
With the help of the Founder of CaRAVAN, we launched the POWER-OF-ONE FELLOWSHIP and raised over $150,000+.
We are excited to announce our first fellow to receive the award is:
C. Griffin McDaniel, MD-PhD student at University of Cincinnati College of Medicine & Cincinnati Children's Hospital.
Coming Soon: Request for Applications for Medical Student Summer Scholarships, and MD/PhD Power of One Scholarships to support a MD, PhD or MD-PhD students to complete their dissertation or capstone work in the lab of one of our vascular anomaly experts.
Please use the Contact Us page to learn more.
Meet Charles "Griffin" McDaniel MD-PhD candidate class of 26
Power-of-One Fellowship awarded to C. Griffin McDaniel, MD-PhD Student at University of Cincinnati College of Medicine & Cincinnati Children’s Hospital, to research kaposiform lymphangiomatosis (KLA)
Kaposiform Lymphangiomatosis (KLA) is a rare and life-threatening lymphatic disease that affects children and young adults.
Currently, patients with KLA are not cured by the available treatments and can suffer from devastating and often fatal complications from the disease.
C. Griffin McDaniel, an MD-PhD student in the Medical Scientist Training Program (MSTP) at University of Cincinnati College of Medicine, has been awarded the inaugural Power-of-One fellowship to support his research while he completes his PhD training studying the causes of KLA in the laboratory of Dr. Tim Le Cras at Cincinnati Children’s Hospital.
Griffin’s research aims to better understand the disease-causing pathways in KLA, while developing new and improved therapies.
The fellowship name represents the idea that one patient can make a difference in research.
Thanks to this support from CaRAVAN and the Complex Lymphatic Anomaly (CLA) community, Griffin has already made an excellent start, contributing to the literature by authoring the first ever comprehensive review article on the diagnosis and treatment of KLA, all while completing his second year of medical school.
This review* has been published in the journal Pediatric Blood and Cancer and includes state-of-the-art diagnostic techniques, current treatments, patient/ family support, and gaps in research on KLA.
Because of the opportunity and support this fellowship provides and because of the dedication from students like Griffin and his mentor Dr. Tim Le Cras, there is HOPE for improved outcomes and a brighter future for children and their families living with KLA and other related lymphatic diseases.
Click below for link to the published work on KLA:
*McDanielCG,AdamsDM,SteeleKE,etal.Kaposiformlymphangiomatosis:Diagnosis,pathogenesis,andtreatment.Pediatr Blood Cancer.2023;e30219.
CaRAVAN Network's next Fellowship Campaign:
THE POWER OF TWO Fellowship Fundraiswer is here!
Donate today to support an early investigator in a vascular anomalies research lab. Click the link below.
Your donation helps support our organization's mission to make a positive impact in the community. We appreciate your generosity and support!
Written by Oliwia Mruk
I am a final Biological Sciences (Bioinformatics) student, interested in multidisciplinary approach to research. I joined the Madsen Lab (Ralitsa Madsen | MRC PPU) in summer of 2023 as Research Student through the Biochemical Society's Summer Vacation Studentship, followed by undertaking an Honours project under Dr Madsen's supervision and joining as a Research Technician.
When not in the lab, I am an advocate of collaborative and open science, patient advocacy and transparency, connecting scientists through conferences/events and sharing my experience through the STEM Ambassadors programme.
To learn more about CaRAVAN's Summer Scholarships for Students Interested in Vascular Anomalies - contact us now! firstname.lastname@example.org
Funding Opportunities for 2023
For submission Instructions & Program Announcements click here:
Funding is available to all researchers globally.
Pre-application deadlines range from March 29, 2023 to April 19, 2023
This is a great opportunity for the lymphatic community. Thanks to the Lymphatic Education and Research Network, Lymphedema Lymphatic Disease | Lymphatic Education & Research Network (lymphaticnetwork.org), this year is the first time that "Lymphatic Diseases and Lymphedema" have made it to the top 50 prioritized categories for funding.
The Lymphatic Education & Research Network (LE&RN) will host a virtual webinar on February 28, 2023 at 1pm EST with Dr. Cecelia Dupecher, Program Manager for the Peer Reviewed Medical Research Program (PRMRP) at CDMRP.
Click here to register: Webinar Registration - Zoom
1. Genetic Basis and Therapies for Vascular Anomalies
2. ISSVA Classification of Vascular Anomalies and Molecular Biology
3. Kaposiform lymphangiomatosis: Diagnosis, pathogenesis and treatment